Outsourced Pharma Announces Inaugural Editorial Advisory Board

Erie, PA – Outsourced Pharma is dedicated to pharmaceutical drug development services. With regular sections on drug development, contract manufacturing, contract research services, contract packaging services, formulation and development, API manufacturing, and more, we bring complete coverage of outsourcing trends and issues to the pharmaceutical contract development and manufacturing marketplace. Our goal is to help facilitate connections and faster collaborations between sponsors and CMOs and other equipment and service providers.  

To ensure we are providing readers with the content they will find timely and valuable, we rely on the feedback of pharma industry professionals and consultants to guide our focus and direction. With that in mind, we are proud to announce the launch of our inaugural editorial advisory board for the website. The board, made up of consultants and executives from the pharma and bio industries, will help guide the direction and focus of the site’s editorial content.

The following individuals have volunteered to be the initial editorial advisory board members:

Roger Bakale, VP, CMC and Supply Chain, Receptos

Peter Bigelow, President, xCell Strategic Consulting

Herman Bozenhardt, Principal, Bozenhardt Consulting Services LLC

Sean Bradley, Director of CMC, On Target Laboratories

Ron Branning, President, Ron Branning Consulting

Tony Brazzale, CEO, Gordian Biotechnologies

David Casebier, VP of CMC, Navidea Biopharmaceuticals

Darren Dasburg, VP BioVentures – Biologics, AstraZeneca

Chuck Forsaith, Director, Supply Chain Security, Purdue Pharma Technologies

Rajiv Ginde, Associate Director, NA Strategic Procurement, Finished Dosage Forms, Sandoz

Peter Grebow, Director, P. E. Grebow Consulting

Angie Green, VP, Manufacturing and Supply Chain, PTC Therapeutics

Brian James, VP Operations and Managing Director, Rondaxe

Sonia Kansal, Associate Director/Senior ManagerHead, Pfizer Worldwide R&D

Ravi Kiron, Managing Partner, BioPharm Strategy Advisors, Inc.

Michael Martorelli, Director, Fairmount Partners

Andrew Reaume, President & CEO, Melior Discovery

Scott Zook, Senior Director of Chemical Development, Neurocrine Biosciences Inc.

We look forward to working with these individuals and making sure the articles we publish continue to provide you with actionable information that will help make your company more profitable.

The editorial advisory board page can be seen here.